Vision Loss Impact on Navigation in Virtual Reality
University of Rochester · with Rochester Institute of Technology · NCT06047717
Opens the official ClinicalTrials.gov record, with the study team’s contacts. Bored Studies doesn’t enroll anyone.
Key facts
- Compensation
- Not posted. Ask the study team before screening.
- Who can join
- Ages 21–75 · All sexes
- Healthy volunteers
- Accepted
- Study type
- Interventional · Not applicable
- Target enrollment
- 40
- US sites recruiting
- 1
- Study start
- November 28, 2023
- Record last updated
- August 25, 2026
Status re-checked against ClinicalTrials.gov within the last 12 hours.
What the study is about
The purpose of this research is to better understand the impact of cortically-induced blindness (CB) and the compensatory strategies subjects with this condition may develop on naturalistic behaviors, specifically, driving. Using a novel Virtual Reality (VR) program, the researchers will gather data on steering behavior in a variety of simulated naturalistic environments. Through the combined use of computer vision, deep learning, and gaze-contingent manipulations of the visual field, this work will test the central hypothesis that changes to visually guided steering behaviors in CB are a consequence of changes to the visual sampling and processing of task-related motion information (i.e., optic flow).
Being studied: Virtual Reality Driving Task
Conditions: Stroke, Ischemic; Quadrantanopia; Hemianopsia, Homonymous; Hemianopia, Homonymous; Hemianopia; Hemianopsia; Occipital Lobe Infarct; Visual Field Defect, Peripheral; Vision Loss Partial; Quadrantanopsia; Stroke Hemorrhagic
Eligibility criteria
Copied from the official record. The study team makes the final decision at screening.
Show full criteria
Cortically Blind Group
Inclusion Criteria
- Residents of the United States or Canada
- Presence of one-sided stroke or stroke-like damage to primary visual cortex or its immediate afferent white matter sustained within the specified age range of 21 - 75 years (verified by MRI and/or CT scans)
- Reliable visual field defects in both eyes (homonymous defects) as measured by Humphrey or equivalent perimetry.
- Willing, able, and competent to provide their own informed consent
- Cognitively able, responsible to understand written and oral instructions in English
- Emmetropic or else wear corrective contact lenses inside the virtual reality headset
Exclusion Criteria
- Those who have never driven or earned a drivers' license
- Past or present ocular disease interfering with visual acuity
- Best corrected visual acuity (BCVA) worse than 20/40 in either eye
- Sustained damage to the dorsal lateral geniculate nucleus
- Presence of diffuse, whole-brain degenerative processes
- Presence of brain damage deemed by study staff to potentially interfere with outcome measures
- History of traumatic brain injury
- Documented history of drug/alcohol abuse
- Diagnosis of cognitive or seizure disorders
- Diagnosis of one-sided attentional neglect
Control Group
Inclusion Criteria
- Normal or corrected-to-normal vision, who are between the ages of 21 and 75 years of age, roughly matched to the age of CB subjects enrolled above
- Competent and responsible, as determined by the Principal Investigator
- Willing, able, and competent to provide their own informed consent
- Normal cognitive abilities, be able to understand written and oral instructions in English
- Emmetropic or else wear corrective contact lenses inside the virtual reality headset
Exclusion Criteria
- Subjects who have never driven or earned a drivers' license
- BCVA worse than 20/40 in either eye
- Presence of vision loss from ocular diseases or disorders
- Presence of a visual field defect
- Inability to wear corrective contact lenses inside the virtual reality helmet if required to see clearly
- Subjects with a history of neurological disorders
- Subjects with a history of TBI
- Persons who lack the competence or are otherwise unable to perform the visual testing as directed.
Recruiting US locations
University of Rochester
Rochester, NY 14642
Site contact: Evan Burr · 585-275-5234 · Evan_Burr@urmc.rochester.edu
Study contacts (from the official record)
- Evan Burr · 585-275-5234 · Evan_Burr@URMC.Rochester.edu
Similar studies in New York
All neurology studies in New York →- RecruitingHealthy volunteersPhase 1
Dose Escalation Study to Assess the Safety, Tolerability, Pharmacokinetics And Pharmacodynamics of SIF001 in Healthy Subjects and in Epilepsy Patients
Suninflam Inc
- Location
- Amherst, NY + 9 other US sites
- Eligibility basics
- Ages 18–70
- RecruitingHealthy volunteersEarly Phase 1
Chronic Transcutaneous Stimulation to Promote Motor Function and Recovery in Individuals With Paralysis or Paresis
Northwell Health
- Location
- Manhasset, NY
- Eligibility basics
- Ages 18–75
- RecruitingHealthy volunteersPhase 1
Repetitive Transcranial Magnetic Stimulation for Post-concussion Headaches
State University of New York - Upstate Medical University
- Location
- Syracuse, NY
- Eligibility basics
- Ages 18–55
- RecruitingHealthy volunteers
MyVitalC: Sleep and Everyday Headache Management
Efforia, Inc
- Location
- New York, NY
- Eligibility basics
- Any age listed